A groundbreaking therapy based on transplanting mitochondria into blood stem cells has shown encouraging results in an ongoing, phase 2 trial. If successful, the therapy could not only treat rare, incurable diseases, but also potentially help reverse some of the...

A team of scientists at UCLA has shown it’s possible to reprogram hematopoietic stem cells to generate a regular supply of cancer-killing T cells. This novel approach, tested in a first-of-its-kind clinical trial the results of which were published in Nature...

The first in-human trial of a stem cell therapy to treat hearing loss is due to begin later this year in the UK, after receiving approval from the Medicines and Healthcare products Regulatory Agency (MHRA). The trial will test whether the treatment is safe, as well as...

The liver is a remarkably resilient organ - the only organ in the body capable of regenerating itself when damaged.[1] Damage to the liver does, however, build up over time, eventually leading first to chronic (long-term) liver disease and then, inevitably, to liver...